Cholestatic jaundice associated with lovastatin (Mevacor) therapy.
McQueen
M J
MJ
McMaster University, Hamilton, Ont.
D000328:Adult; D002779:Cholestasis / Q000139:chemically induced* / Q000175:diagnosis; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D004796:Clinical Enzyme Tests; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy; D008148:Lovastatin / Q000009:adverse effects*; D008297:Male; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol; D008148:Lovastatin